Loomis, Sayles & Company
PRCT icon

Loomis, Sayles & Company’s Procept Biorobotics PRCT Stock Holding History

Loomis, Sayles & Company’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-983,903
Closed -$35.1M – 746
2025
Q3 		$35.1M Sell
983,903
-187,408
-16% -$8.56M 0.04% 152
2025
Q2 		$67.5M Sell
1,171,311
-9,989
-0.8% -$565K 0.08% 86
2025
Q1 		$68.8M Sell
1,181,300
-25,760
-2% -$1.76M 0.1% 79
2024
Q4 		$97.2M Sell
1,207,060
-36,207
-3% -$3.09M 0.12% 69
2024
Q3 		$99.6M Sell
1,243,267
-18,341
-1% -$1.3M 0.13% 69
2024
Q2 		$77.1M Sell
1,261,608
-89,392
-7% -$5.32M 0.11% 76
2024
Q1 		$66.8M Buy
1,351,000
+34,292
+3% +$1.63M 0.1% 91
2023
Q4 		$55.2M Sell
1,316,708
-28,746
-2% -$979K 0.08% 112
2023
Q3 		$44.1M Buy
1,345,454
+636,750
+90% +$21.7M 0.08% 123
2023
Q2 		$25.1M Sell
708,704
-6,688
-0.9% -$221K 0.04% 218
2023
Q1 		$20.3M Buy
715,392
+132,775
+23% +$4.68M 0.04% 238
2022
Q4 		$24.2M Buy
+582,617
New +$25M 0.05% 205

Other funds holding PRCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company's PRCT Position: Q4 2025 in Review

Loomis, Sayles & Company sold out of Procept Biorobotics (PRCT) in Q4 2025, closing a stake of 983,903 shares — an estimated $35.1M sold.

Loomis, Sayles & Company first reported a position in PRCT in Q4 2022 and held it in 12 quarters. The position peaked at $99.6M in Q3 2024. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • Loomis, Sayles & Company reported no remaining Procept Biorobotics position as of Q4 2025 after selling out during the quarter.
  • Loomis, Sayles & Company sold 983,903 Procept Biorobotics shares in Q4 2025, an estimated $35.1M.
  • Loomis, Sayles & Company first reported a position in Procept Biorobotics in Q4 2022 and held it in 12 quarters.
  • Loomis, Sayles & Company's Procept Biorobotics position peaked at $99.6M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on Loomis, Sayles & Company's 13F filing for Q4 2025, filed 12 Feb 2026.